Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      CanSino, Johnson & Johnson vaccines approved for conditional use in M'sia
      Malaysiakini
      News
      CanSino, Johnson & Johnson vaccines approved for conditional use in M'sia

      CanSino, Johnson & Johnson vaccines approved for conditional use in M'sia

      Published: Jun 15, 2021 6:09 AM | Updated: Jun 15, 2021 7:29 AM

      Covid-19 vaccines from China’s CanSino Biologics and the US’ Johnson & Johnson, both of which only require one dose to be effective, have been given conditional approval for use in Malaysia, said Health Ministry director-general Dr Noor Hisham Abdullah.

      The Drug Control Authority (DCA), in its meeting today, also approved Pfizer-BioNTech’s Covid-19 vaccine for children as young as 12 years old, he added...

      MP SPEAKS | What is the role of NPRA in vaccine registration?

      MP SPEAKS | What is the role of NPRA in vaccine registration?

      DCA grants conditional registration for Ravida tablets

      DCA grants conditional registration for Ravida tablets

      DCA approves Pharmaniaga-produced Sinovac vaccine

      DCA approves Pharmaniaga-produced Sinovac vaccine

      China to study using CanSinoBIO Covid shots as a booster

      China to study using CanSinoBIO Covid shots as a booster

      Vaccines vs Variants: What we know so far?

      Vaccines vs Variants: What we know so far?

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      MP SPEAKS | What is the role of NPRA in vaccine registration?

      10-06-2021

      DCA grants conditional registration for Ravida tablets

      04-06-2021

      DCA approves Pharmaniaga-produced Sinovac vaccine

      23-04-2021

      China to study using CanSinoBIO Covid shots as a booster

      09-06-2021

      Vaccines vs Variants: What we know so far?

      18-05-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor